[Huang, Shifang; Luo, Xuling; Jiang, Jinyong; Huang, Zhen; Liu, Meiqing; Hu, Haoliang; Li, Yao; Li, Lanfang; Wang, Lingzhi; He, Lu; Chen, Zhe; Cao, Jiangang; Chen, Linxi] Univ South China, Inst Pharm & Pharmacol, Hunan Prov Cooperat Innovat Ctr Mol Target New Dru, Hengyang Med Sch,Hunan Prov Key Lab tumor Microenv, Hengyang, Peoples R China.

[Hu, Haoliang] Hunan Univ Arts & Sci, Coll Life & Environm Sci, Changde Res Ctr Artificial Intelligence & Biomed, Changde, Hunan, Peoples R China.

[Hu, Haoliang; Li, Lanfang; Chen, Linxi] Univ South China, Inst Pharm & Pharmacol, Coll Basic Med Sci, Hunan Prov Cooperat Innovat Ctr Mol Target New Dru, Hengyang 421001, Peoples R China.

[Haoliang Hu; Lanfang Li; Linxi Chen; Haoliang Hu Haoliang Hu Haoliang Hu; Lanfang Li Lanfang Li Lanfang Li; Linxi Chen Linxi Chen Linxi Chen] H

Hunan Provincial Key Laboratory of tumor microenvironment responsive drug research, Hengyang Medical School, Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China<&wdkj&>Changde Research Center for Artificial Intelligence and Biomedicine, College of Life and Environmental Sciences, Hunan University of Arts and Science, Changde, Hunan, China<&wdkj&>Hunan Provincial Key Laboratory of tumor microenvironment responsive drug research, Hengyang Medical School, Institute of Pharmacy and Pharmacology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, University of South China, Hengyang, China

cobicistat;elabela-apelin/APJ system;pannexin1;Schisandrin A;thrombosis

药学与生物科学学院